Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors

This document is a response-to-comments notice for the MolDX Local Coverage Determination DL38045 (Next‑Generation Sequencing for Solid Tumors). The public comment period ran from 2019-05-06 to 2019-06-20; the notice period begins 2019-12-06 and the policy is effective 2020-02-10. No clinical coverage criteria are provided within this administrative response document.

"Administrative notice: public comment period for MolDX LCD DL38045 (Next-Generation Sequencing for Solid Tumors) ran 2019-05-06 to 2019-06-20; notice period begins 2019-12-06 and the policy becomes..."

Sign up to see full coverage criteria, indications, and limitations.